Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013-2018.
Despite increases in opioid prescribing and related morbidity and mortality, few studies have comprehensively documented harms across opioid types. We examined a population-wide indicator of extramedical pharmaceutical opioid-related harm to determine if the supply-adjusted rates of ambulance presentations, the severity of presentations or other attendance characteristics differed by opioid type. Retrospective observational study of coded ambulance patient care records related to extramedical pharmaceutical opioid use, January 2013 to September 2018. Australia CASES: Primary analyses used Victorian data (n=9,823), with available data from other Australian jurisdictions (n=4,338) used to determine generalisability. We calculated supply-adjusted rates of attendances using Poisson regression, and used multinomial logistic regression to compare demographic, presentation severity, mental health, substance use and other characteristics of attendances associated with seven pharmaceutical opioids. In Victoria, the highest rates of attendance (per 100,000 Oral Morphine Equivalent mg[OME]) were for codeine (0·273/100,000) and oxycodone (0·113/100,000). The lowest rates were for fentanyl (0·019/100,000) and tapentadol (0·005/100,000). Oxycodone-naloxone rates (0·031/100,000) were lower than for oxycodone as a single ingredient (0·113/100,000). Fentanyl-related attendances were associated with the most severe characteristics, most likely to be an accidental overdose, most likely to have naloxone administered, and least likely to be transferred to hospital. In contrast, codeine-related attendances were more likely to involve suicidal thoughts/behaviours, younger females, and be transported to hospital. Supply-adjusted attendance rates for individual opioids were stable over time. Victorian states were broadly consistent with non-Victorian states. In Australia, rates and characteristics of opioid-related harm vary by opioid type. Supply-adjusted ambulance attendance rates appear to be both stable over time and unaffected by large changes in supply. This project was funded by an untied educational grant from Seqirus Pty Ltd. SN is the recipient of an NHMRC Career Development Fellowship (1163961). The Ambo Project and National Ambo Project are funded by the Victorian Department of Health and Human Services, and the Commonwealth Department of Health. Funders had no role in the study design, conduct, analysis, or interpretation. SN is a named investigator on research grants from Indivior (unrelated to this work), and has delivered presentations on codeine dependence for Indivior for which her institution received payment. DL has received speaking honoraria from the following: AstraZeneca, Camurus AB, Indivior, Janssen-Cilag, Lundbeck, Servier and Shire, and has participated on Advisory Boards for Indivior and Lundbeck.